![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Shaheed Beheshti Medical University |
---|---|
Information provided by: | Shaheed Beheshti Medical University |
ClinicalTrials.gov Identifier: | NCT00372294 |
Toxoplasmosis, an intra cellular parasite, is a very important cause of chorioretinitis. The goal of treatment is arresting multiplication of the parasite in its inflammatory active phase. In this study the investigators try to compare the efficacy of the classic regimen (Pyrimethamine-Sulfadiazine + Prednisolon) with intravitreal Clindamycin & Dexamethasone.
Condition | Intervention | Phase |
---|---|---|
Chorioretinitis |
Drug: pyrimethamine-sulfadiazine + prednisolone Drug: Clindamycin+Dexamethasone |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Subject), Active Control, Parallel Assignment, Safety/Efficacy Study |
Study Start Date: | July 2005 |
Estimated Study Completion Date: | November 2008 |
Estimated Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
Classic regimen (Pyrimethamine-Sulfadiazine + Prednisolon)
|
Drug: pyrimethamine-sulfadiazine + prednisolone
Administration of pyrimethamine-sulfadiazine + prednisolone
|
2: Active Comparator
Intravitreal Clindamycin & Dexamethasone
|
Drug: Clindamycin+Dexamethasone
Intravitreal injection of Clindamycin+Dexamethasone
|
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Iran, Islamic Republic of | |
Ophthalmic Research Center | |
Tehran, Iran, Islamic Republic of, 16666 |
Principal Investigator: | Masoud Soheilian, MD | Ophthalmic Research Center of Shaheed Beheshti Medical University |
Study ID Numbers: | 8415 |
Study First Received: | September 5, 2006 |
Last Updated: | July 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00372294 |
Health Authority: | Iran: Ethics Committee |
Toxoplasmosis Chorioretinitis Intravitreal Clindamycin Dexamethasone in chorioretinitis Toxoplasmic |
Dexamethasone Panuveitis Pyrimethamine Clindamycin Clindamycin-2-phosphate Methylprednisolone Uveitis, Posterior Eye Diseases Choroid Diseases Retinitis Methylprednisolone acetate |
Prednisolone acetate Toxoplasmosis Folic Acid Uveitis Choroiditis Prednisolone Sulfadiazine Chorioretinitis Dexamethasone acetate Retinal Diseases Methylprednisolone Hemisuccinate |
Anti-Inflammatory Agents Anti-Infective Agents Antiprotozoal Agents Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Antiemetics Hormones Neuroprotective Agents Anti-Bacterial Agents Antimalarials Antiparasitic Agents Therapeutic Uses |
Coccidiostats Uveal Diseases Antineoplastic Agents, Hormonal Gastrointestinal Agents Enzyme Inhibitors Folic Acid Antagonists Glucocorticoids Protective Agents Pharmacologic Actions Protein Synthesis Inhibitors Autonomic Agents Peripheral Nervous System Agents Central Nervous System Agents |